Unfolding Worldwide Market Opportunity for Cancer Vaccines

Unfolding Worldwide Market Opportunity for Cancer Vaccines

 

RELEASE DATE
11-Jun-2004
REGION
Global
Research Code: A891-01-00-00-00
SKU: HC00983-GL-MR_04879
AvailableYesPDF Download
$3,950.00
In stock
SKU
HC00983-GL-MR_04879
$3,950.00
DownloadLink
ENQUIRE NOW

Description

This research service includes many aspects of the product analysis for the cancer vaccines market including: drivers, restraints, existing market trends, pipeline trends, challenges, strategic company profiles, financial analysis and awards. Prevalence, average selling prices, and revenue forecasts provide market opportunity for cancer vaccines.

Table of Contents

Overview

  • Introduction
  • Disclaimer
  • Certification
  • Research Scope And Methodology
  • Study Objectives
  • Market Segmentation By Cancer Sites
  • Market Segmentation By Geographical Regions
  • Key Definition-1
  • CEO Quote
  • Key Definition-2
  • Key Definition-3
  • Key Definition-4

Market Dynamics

  • Industry Challenges
  • Radar Screen: Cancer Vaccine Companies
  • CEO Quote

Demand Analysis

  • Prevalence of Key Cancers (U.S.)
  • Prevalence of Key Cancers (E.U.)
  • Incidence of Prostate Cancer (World)-1
  • Incidence of Prostate Cancer (World)-2
  • Incidence of Breast Cancer (World)-1
  • Incidence of Breast Cancer (World)-2
  • Incidence of Colon Rectum Cancer (World)-1
  • Incidence of Colon Rectum Cancer (World)-2
  • Key Drivers
  • CEO Quote

Pipeline Analysis and Product Profiles

  • Cancer Vaccines Pipeline Chart
  • Lead Stage Cancer Vaccine Products
  • Product Profile: AVICINE
  • Product Profile: Canvaxin
  • Product Profile: GMK Cancer Vaccine
  • Product Profile: MyVax
  • Product Profile: Oncophage
  • Product Profile: OncoVAX
  • Product Profile: Provenge
  • Product Profile: Theratope
  • CEO Quote

Market Revenue Forecast

  • Forecast Assumptions
  • Revenue Forecast - Prostate Cancer (U.S.)
  • Revenue Forecast - Prostate Cancer (U.S.)
  • Revenue Forecast - Breast Cancer (U.S.)
  • Revenue Forecast - Melanoma (U.S.)
  • Revenue Forecast - Colon Rectum Cancer (U.S.)
  • Revenue Forecast - Prostate Cancer (E.U.)
  • Revenue Forecast - Breast Cancer (E.U.)
  • Revenue Forecast - Colon rectum cancer (E.U.)
  • Revenue Forecast - Melanoma (E.U.)
  • Total Market Revenue Forecast
  • Total World Market For Cancer Vaccines
  • Percentage of Revenues by Product Type
  • CEO Quote

Company Profile and Strategy Analysis

  • Company Profile : Antigenics
  • Company Profile : AVI Biopharma
  • Company Profile : Biomira
  • Company Profile : CancerVax
  • Company Profile : Dendreon
  • Company Profile : Genitope
  • Company Profile : Intracel
  • Product Marketing Strategy Analysis
  • Cancer vaccines: Technology Challenge
  • CEO Quote

Awards

  • Introduction
  • Entrepreneurial Company Award
  • Product Innovation Award
  • Technology Leadership Award

Econometrics

  • Macro Economic Analysis - I
  • Macro Economic Analysis - II
  • Macro Economic Analysis - III
  • Macro Economic Analysis - IV

Frost & Sullivan

  • Healthcare Team
  • Our Capabilities
  • Key Advantages
  • Our Consulting Clients
  • Growth Consulting
  • Growth Consulting Process
  • Growth Consulting Deliverables
  • Growth Partnership Service
  • Growth Partnership Services Program
Related Research
This research service includes many aspects of the product analysis for the cancer vaccines market including: drivers, restraints, existing market trends, pipeline trends, challenges, strategic company profiles, financial analysis and awards. Prevalence, average selling prices, and revenue forecasts provide market opportunity for cancer vaccines.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A891-01-00-00-00
Is Prebook No